HPV16+ SQUAMOUS CELL CARCINOMA

Clinical trials for HPV16+ SQUAMOUS CELL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new HPV16+ SQUAMOUS CELL CARCINOMA trials appear

Sign up with your email to follow new studies for HPV16+ SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Experimental treatment targets hidden cancer cells in blood

Disease control Ongoing

This early-stage study is testing whether HB-200 treatment can help people with HPV16-positive head and neck cancer who have completed standard treatment but still show signs of cancer DNA in their blood. The trial involves 7 patients who have no visible cancer on scans but test …

Matched conditions: HPV16+ SQUAMOUS CELL CARCINOMA

Phase: EARLY_PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

HPV16+ SQUAMOUS CELL CARCINOMA

Get alerted when new HPV16+ SQUAMOUS CELL CARCINOMA trials appear

Experimental treatment targets hidden cancer cells in blood